United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...

Despite many overseas drugmakers gaining some tariff clarity when the U.S. | Thanks to a new accord with the United States, ...

U.S. health authorities are considering how they might discourage or even ban vaccines that rely on a common ingredient to ...

In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...

Building on the company's validated enzymatic process for green ibuprofen synthesis, the expanded program leverages Quantumzyme's enzyme families, machine learning predictive models, and in silico ...

What seems certain is that space and low-orbit laboratories will become an integral tool for drug innovation within the ...

The plans could be related to $23 billion effort by Swiss pharmaceutical Novartis to expand its manufacturing capabilities in ...

Chennai: Solara Active Pharma Sciences Limited, an Active Pharmaceutical Ingredient provider, has announced that its ...

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

India a reliable partner for Bangladesh in API sourcing, technologies, and pharma machinery, said Pranay Verma ...